Contrast enhanced harmonic ultrasound for differentiating breast tumors - first results.

PURPOSE To investigate the extent to which indeterminate lesions of the breast can be differentiated in the early and late phase after bolus injection of the ultrasound contrast medium Optison. MATERIALS AND METHODS Fifty female patients (mean age: 49 years) with a altogether 53 preoperatively impalpable indeterminate breast tumors, 20 fibroadenomas and 33 carcinomas, were examined by B-mode imaging and contrast medium-enhanced ultrasound with power Doppler (three patients had multifocal carcinomas). The tumors had a diameter of 5-15 mm (mean diameter: 9 mm). Histological confirmation was performed in all lesions by vacuum biopsies and/or surgical preparation. All examinations were performed with a multifrequency linear array probe (5-10 MHz, Logiq9 and Logiq 7, GE). Power Doppler (PD) and B-mode imaging as well as tissue harmonic imaging (THI) were employed. A bolus of 0.5 ml Optison was injected intravenously and spreading of the contrast enhancement and washout in the tumors were followed for at least 20 minutes. A low mechanical index was chosen to avoid early destruction of the microbubbles. Maximum tumor size was measured and tumors vessels were evaluated in digital cine ultrasound sequences. RESULTS Without CM administration, 14 of 19 tumor lesions smaller than 10 mm could be distinguished better from the surrounding tissue with THI compared to fundamental B-mode imaging. Both benign (17/20) and malignant (30/33) tumors exhibited increased tumor marginal vessels or intratumoral vessels in the early phase after CM injection. A diffuse contrast medium accumulation was observed in the late phase (8-18 min, mean: 12 min) in 30 of 33 malignant tumors, but in none of the benign tumors. The diagnostic confirmation for this late enhancement was there with 90% for the malignant tumors. CONCLUSION After intravenous bolus administration of Optison, breast carcinomas appear to have a prolonged diffuse enhancement of central tumor vasularity in the late phase compared to an earlier marginal vascularity of fibroadenomas.

[1]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[2]  V. R. McCready,et al.  Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. , 1996, Radiology.

[3]  S. Raza,et al.  Solid breast lesions: evaluation with power Doppler US. , 1997, Radiology.

[4]  R. Jeffrey,et al.  Preliminary experience with power Doppler imaging of solid breast masses. , 1997, AJR. American journal of roentgenology.

[5]  D. Mcclelland,et al.  Safety of human albumin as a constituent of biologic therapeutic products , 1998, Transfusion.

[6]  J Kettenbach,et al.  Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience. , 1998, Radiology.

[7]  S. Delorme,et al.  [Dynamic assessment of contrast medium enhancement in Doppler ultrasound imaging. Current status]. , 1998, Der Radiologe.

[8]  Power Doppler sonography of breast cancer: does vascularity correlate with node status or lymphatic vascular invasion? , 1999, AJR. American journal of roentgenology.

[9]  H. Dittrich,et al.  Evaluation of myocardial, hepatic, and renal perfusion in a variety of clinical conditions using an intravenous ultrasound contrast agent (Optison) and second harmonic imaging , 1999, Heart.

[10]  G. Brandenburger,et al.  Effects of transducer frequency and output power on the ultrasonographic contrast produced by Optison using fundamental and harmonic imaging techniques. , 1999, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[11]  H. Dittrich,et al.  Cardiac imaging using Optison. , 2000, The American journal of cardiology.

[12]  B. Goldberg,et al.  Breast tumor vascularity identified by contrast enhanced ultrasound and pathology: initial results. , 2000, Ultrasonics.

[13]  K. Holz,et al.  The role of enhanced Doppler Ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancy , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[14]  D. Noh,et al.  Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience. , 2000, Radiology.

[15]  M. Schietzel,et al.  Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography. , 2000, AJR. American journal of roentgenology.

[16]  G. Hommel,et al.  Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy. , 2000, Clinical hemorheology and microcirculation.

[17]  M. Kessler,et al.  Evaluation of breast lesions by power Doppler sonography , 2001, European Radiology.

[18]  J. Chang,et al.  Benign and malignant breast masses and axillary nodes: evaluation with echo-enhanced color power Doppler US. , 2001, Radiology.

[19]  L. Alamo,et al.  Contrast-enhanced color Doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRI , 2001, European Radiology.

[20]  S. Delorme,et al.  Fibroadenomas: computer-assisted quantitative evaluation of contrast-enhanced power Doppler features and correlation with histopathology. , 2001, Ultrasound in medicine & biology.

[21]  J. Jauhiainen,et al.  B-Mode, power doppler and contrast-enhanced power doppler ultrasonography in the diagnosis of breast tumors , 2001 .

[22]  R. Felix,et al.  Vaskularisationsanalyse bei Mammatumoren - Vergleich von Hochfrequenzsonographie und Kontrast-Colour-Harmonic-Imaging , 2002 .

[23]  T. M. Kolb,et al.  Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. , 2002, Radiology.

[24]  R. Felix,et al.  [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging]. , 2002, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[25]  E. Jung,et al.  [B-flow and contrast medium-enhanced power Doppler (Optison(R))--preoperative diagnosis of high-grade stenosis of the internal carotid artery]. , 2002, RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (Print).

[26]  D. Clevert,et al.  B-Flow und kontrastmittelverstärkter Power Mode mit Optison®: Präoperative Diagnostik der hochgradigen Stenose der A. carotis interna , 2002 .

[27]  [Scar or recurrence--comparison of MRI and color-coded ultrasound with echo signal amplifiers]. , 2002, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[28]  M. Lell,et al.  Narbe oder Rezidiv? Einsatz der signalverstärkten Doppler-Sonographie im Vergleich zur MRT , 2002 .

[29]  François Tranquart,et al.  In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours. , 2002, Ultrasound in medicine & biology.

[30]  W. Kaiser,et al.  [Prospective analysis of quantification of contrast media enhanced power Doppler sonography of equivocal breast lesions]. , 2003, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[31]  R. Xiu,et al.  A proteomic study on cell cycle progression of endothelium exposed to tumor conditioned medium and the possible role of cyclin D1/E. , 2003, Clinical hemorheology and microcirculation.

[32]  K. Han,et al.  Breast lesions on sonograms: computer-aided diagnosis with nearly setting-independent features and artificial neural networks. , 2003, Radiology.

[33]  E. Jung,et al.  [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors]. , 2003, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[34]  R. Abarquez,et al.  Microcirculation: target therapy in cardiovascular diseases - a clinical perspective. , 2003, Clinical hemorheology and microcirculation.

[35]  Tejas Mehta,et al.  Current uses of ultrasound in the evaluation of the breast. , 2003, Radiologic clinics of North America.

[36]  C. Marx,et al.  Computerassistierte Quantifizierungsanalyse der kontrastmittelverstärkten Powerdoppler-Sonographie bei unklaren Herdbefunden der Mamma , 2003 .

[37]  P. Burns,et al.  Blood flow patterns in focal liver lesions at microbubble-enhanced US. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[38]  M. Kohno,et al.  Interaction with leukocytes: phospholipid-stabilized versus albumin-shell microbubbles. , 2004, Radiology.